Financials
- Market Capitalization 146.98 M
- Employee 56
- Founded 2018
- CEO N/A
- Website www.pyxisoncology.com
- Headquarter Delaware, United States
- FIGI BBG00PQFFCV5
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3770 | MIST Milestone Pharmaceuticals Inc. - Common Shares | 1.30 USD | +1.56% | 0.00% | 0.00% | -8.45% | 161.85 M USD | ||
| 3773 | ADCT ADC Therapeutics SA Common Shares | 1.24 USD | -0.80% | -0.80% | +14.81% | -62.99% | 157.72 M USD | ||
| 3802 | HUMA Humacyte, Inc. - Common Stock | 0.70 USD | +1.45% | -6.67% | -35.19% | -71.66% | 155.41 M USD | ||
| 3805 | YDES YD Bio Limited - Ordinary Shares | 2.15 USD | 0.00% | -5.70% | -34.05% | -73.13% | 152.20 M USD |
Frequently asked questions about Pyxis Oncology, Inc. - Common Stock
What is the Pyxis Oncology, Inc. - Common Stock stock price today?
The current price of Pyxis Oncology, Inc. - Common Stock (PYXS) is 2.32. Over the past 24 hours, the stock has changed by -4.92%. Follow the PYXS chart for real-time price dynamics.
What is the stock ticker of Pyxis Oncology, Inc. - Common Stock?
Pyxis Oncology, Inc. - Common Stock trades under the ticker PYXS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Pyxis Oncology, Inc. - Common Stock stock going up?
PYXS has changed by -7.57% over the last week, +31.07% over the last month, and +98.29% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Pyxis Oncology, Inc. - Common Stock net income for the last quarter?
Pyxis Oncology, Inc. - Common Stock reported net income of -23.27 M for the last quarter. The previous quarter showed -18.11 M, which means net income changed by -28.53%.
How many employees does Pyxis Oncology, Inc. - Common Stock have?
As of the latest available data, Pyxis Oncology, Inc. - Common Stock has 56 employees. Workforce size can provide additional context about the company's scale and operations.
What is Pyxis Oncology, Inc. - Common Stock EBITDA?
Pyxis Oncology, Inc. - Common Stock EBITDA is -23.27 M, and its EBITDA margin is -3 687.8%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Pyxis Oncology, Inc. - Common Stock stock?
You can buy Pyxis Oncology, Inc. - Common Stock (PYXS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Pyxis Oncology, Inc. - Common Stock stock?
Investing in Pyxis Oncology, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PYXS chart and related analysis on metatrader.com as part of your research.